Substituted 3-amino-2-mercaptoquinolines as KCNQ2/3 modulators
The invention relates to substituted 3-amino-2-mercaptoquinolines, to processes for their preparation, to medicaments containing these compounds and to the use of these compounds in the preparation of medicaments.
1. A substituted 3-amino-2-mercaptoquinoline of the formula:
wherein
n represents an integer from 1, 2 or 3,
R 1 , R 2 , R 3 and R 4 each independently of the others are selected from the group consisting of H; F; Cl; Br; I; NO 2 ; CF 3 ; CN; OH; OCF 3 ; SH; SCF 3 ; NH 2 ; C 1-6 -alkyl, O—C 1-6 -alkyl, O—C(═O)—C 1-6 -alkyl, S—C 1-6 -alkyl, NH(C 1-6 -alkyl), N(C 1-6 -alkyl) 2 , NH—C(═O)—C 1-6 -alkyl, N(C(═O)—C 1-6 -alkyl) 2 or C(═O)—C 1-6 -alkyl, in each case saturated or unsaturated, branched or unbranched, unsubstituted or mono- or poly-substituted by one or more substituents selected independently of one another from the group consisting of H; F; Cl; Br; I; NO 2 ; CF 3 ; CN; OH; OCF 3 ; SH; SCF 3 ; NH 2 ; C 1-6 -alkyl, O—C 1-6 -alkyl, O—C(═O)—C 1-6 -alkyl, S—C 1-6 -alkyl, NH(C 1-6 -alkyl), N(C 1-6 -alkyl) 2 , NH—C(═O)—C 1-6 -alkyl, N(C(═O)—C 1-6 -alkyl) 2 or C(═O)—C 1-6 -alkyl; C 3-6 -cycloalkyl or heterocyclyl, in each case saturated or unsaturated, unsubstituted or mono- or poly-substituted by one or more substituents selected independently of one another from the group consisting of H; F; Cl; Br; I; NO 2 ; CF 3 ; CN; OH; OCF 3 ; SH; SCF 3 ; NH 2 ; C 1-6 -alkyl, O—C 1-6 -alkyl, O—C(═O)—C 1-6 -alkyl, S—C 1-6 -alkyl, NH(C 1-6 -alkyl), N(C 1-6 -alkyl) 2 , NH—C(═O)—C 1-6 -alkyl, N(C(═O)—C 1-6 -alkyl) 2 or C(═O)—C 1-6 -alkyl;
R 5 is selected from the group consisting of H; F; Cl; Br; I; NO 2 ; CF 3 ; CN; OCF 3 ; SH; SCF 3 ; NH 2 ; C 1-6 -alkyl, O—C 1-6 -alkyl, O—C(═O)—C 1-6 -alkyl, S—C 1-6 -alkyl, NH(C 1-6 -alkyl), N(C 1-6 -alkyl) 2 , NH—C(═O)—C 1-6 -alkyl, N(C(═O)—C 1-6 -alkyl) 2 or C(═O)—C 1-6 -alkyl, in each case saturated or unsaturated, branched or unbranched, unsubstituted or mono- or poly-substituted by one or more substituents selected independently of one another from the group consisting of H; F; Cl; Br; I; NO 2 ; CF 3 ; CN; OH; OCF 3 ; SH; SCF 3 ; NH 2 ; C 1-6 -alkyl, O—C 1-6 -alkyl, O—C(═O)—C 1-6 -alkyl, S—C 1-6 -alkyl, NH(C 1-6 -alkyl), N(C 1-6 -alkyl) 2 , NH—C(═O)—C 1-6 -alkyl, N(C(═O)—C 1-6 -alkyl) 2 or C(═O)—C 1-6 -alkyl; C 3-6 -cycloalkyl or heterocyclyl, in each case saturated or unsaturated, unsubstituted or mono- or poly-substituted by one or more substituents selected independently of one another from the group consisting of H; F; Cl; Br; I; NO 2 ; CF 3 ; CN; OH; OCF 3 ; SH; SCF 3 ; NH 2 ; C 1-6 -alkyl, O—C 1-6 -alkyl, O—C(═O)—C 1-6 -alkyl, S—C 1-6 -alkyl, NH(C 1-6 -alkyl), N(C 1-6 -alkyl) 2 , NH—C(═O)—C 1-6 -alkyl, N(C(═O)—C 1-6 -alkyl) 2 or C(═O)—C 1-6 -alkyl;
R 6a and R 6b each independently of the other represents H; F; Cl; Br; I; methyl; ethyl; n-propyl; isopropyl; n-butyl; sec-butyl; tert-butyl; OH; O-methyl or O-ethyl;
R 7 denotes C 1-8 -alkyl or C 2-8 -heteroalkyl, saturated or unsaturated; branched or unbranched, unsubstituted or mono- or poly-substituted by one ore more substituents selected independently of one another from the group consisting of H; F; Cl; Br; I; NO 2 ; CF 3 ; CN; OH; OCF 3 ; SH; SCF 3 ; NH 2 ; C 1-6 -alkyl, O—C 1-6 -alkyl, O—C(═O)—C 1-6 -alkyl, S—C 1-6 -alkyl, NH(C 1-6 -alkyl), N(C 1-6 -alkyl) 2 , NH—C(═O)—C 1-6 -alkyl, N(C(═O)—C 1-6 -alkyl) 2 or C(═O)—C 1-6 -alkyl; C 3-8 -cycloalkyl or heterocyclyl, saturated or unsaturated, unsubstituted or mono- or poly-substituted by one or more substituents selected independently of one another from the group consisting of H; F; Cl; Br; I; NO 2 ; CF 3 ; CN; OH; OCF 3 ; SH; SCF 3 ; NH 2 ; C 1-6 -alkyl, O—C 1-6 -alkyl, O—C(═O)—C 1-6 -alkyl, S—C 1-6 -alkyl, NH(C 1-6 -alkyl), N(C 1-6 -alkyl) 2 , NH—C(═O)—C 1-6 -alkyl, N(C(═O)—C 1-6 -alkyl) 2 or C(═O)—C 1-6 -alkyl; aryl or heteroaryl, in each case unsubstituted or mono- or poly-substituted by one or more substituents selected independently of one another from the group consisting of H; F; Cl; Br; I; NO 2 ; CF 3 ; CN; NO 2 ; OH; OCF 3 ; SH; SCF 3 ; NH 2 ; C 1-6 -alkyl, O—C 1-6 -alkyl, O—C(═O)—C 1-6 -alkyl, S—C 1-6 -alkyl, NH(C 1-6 -alkyl), N(C 1-6 -alkyl) 2 , NH—C(═O)—C 1-6 -alkyl, N(C(═O)—C 1-6 -alkyl) 2 or C(═O)—C 1-6 -alkyl;
with the proviso that, when R 7 denotes heterocyclyl, the heterocyclyl can be bound via a carbon atom of the heterocyclyl, and
R 8 is selected from the group consisting of C 1-10 -alkyl or C 2-10 -heteroalkyl, in each case saturated or unsaturated, branched or unbranched, unsubstituted or mono- or poly-substituted by one or more substituents selected independently of one another from the group consisting of H; F; Cl; Br; I; NO 2 ; CF 3 ; CN; OH; OCF 3 ; SH; SCF 3 ; NH 2 ; C 1-6 -alkyl, O—C 1-6 -alkyl, O—C(═O)—C 1-6 -alkyl, S—C 1-6 -alkyl, NH(C 1-6 -alkyl), N(C 1-6 -alkyl) 2 , NH—C(═O)—C 1-6 -alkyl, N(C(═O)—C 1-6 -alkyl) 2 or C(═O)—C 1-6 -alkyl; C 3-10 -cycloalkyl or heterocyclyl, in each case saturated or unsaturated, unsubstituted or mono- or poly-substituted by one or more substituents selected independently of one another from the group consisting of H; F; Cl; Br; I; NO 2 ; CF 3 ; CN; OH; OCF 3 ; SH; SCF 3 ; NH 2 ; C 1-6 -alkyl, O—C 1-6 -alkyl, O—C(═O)—C 1-6 -alkyl, S—C 1-6 -alkyl, NH(C 1-6 -alkyl), N(C 1-6 -alkyl) 2 , NH—C(═O)—C 1-6 -alkyl, N(C(═O)—C 1-6 -alkyl) 2 or C(═O)—C 1-6 -alkyl; aryl or heteroaryl, in each case unsubstituted or mono- or poly-substituted by one or more substituents selected independently of one another from the group consisting of H; F; Cl; Br; I; NO 2 ; CF 3 ; CN; OH; OCF 3 ; SH; SCF 3 ; NH 2 ; C 1-6 -alkyl, O—C 1-6 -alkyl, O—C(═O)—C 1-6 -alkyl, S—C 1-6 -alkyl, NH(C 1-6 -alkyl), N(C 1-6 -alkyl) 2 , NH—C(═O)—C 1-6 -alkyl, N(C(═O)—C 1-6 -alkyl) 2 or C(═O)—C 1-6 -alkyl; C 1-8 -alkyl- or C 2-8 -heteroalkyl-bridged C 3-10 -cycloalkyl or heterocyclyl, in each case saturated or unsaturated, unsubstituted or mono- or poly-substituted by one or more substituents selected independently of one another from the group consisting of H; F; Cl; Br; I; NO 2 ; CF 3 ; CN; OH; OCF 3 ; SH; SCF 3 ; NH 2 ; C 1-6 -alkyl, O—C 1-6 -alkyl, O—C(═O)—C 1-6 -alkyl, S—C 1-6 -alkyl, NH(C 1-6 -alkyl), N(C 1-6 -alkyl) 2 , NH—C(═O)—C 1-6 -alkyl, N(C(═O)—C 1-6 -alkyl) 2 or C(═O)—C 1-6 -alkyl, wherein the alkyl or heteroalkyl chain in each case can be branched or unbranched, saturated or unsaturated, unsubstituted; or C 1-8 -alkyl- or C 2-8 -heteroalkyl-bridged aryl or heteroaryl, in each case unsubstituted or mono- or poly-substituted by one or more substituents selected independently of one another from the group consisting of H; F; Cl; Br; I; CF 3 ; CN; OH; OCF 3 ; SH; SCF 3 ; NH 2 ; C 1-6 -alkyl, O—C 1-6 -alkyl, O—C(═O)—C 1-6 -alkyl, S—C 1-6 -alkyl, NH(C 1-6 -alkyl), N(C 1-6 -alkyl) 2 , NH—C(═O)—C 1-6 -alkyl, N(C(═O)—C 1-6 -alkyl) 2 or C(═O)—C 1-6 -alkyl, wherein the alkyl or heteroalkyl chain in each case can be branched or unbranched, saturated or unsaturated, unsubstituted;
said substituted 3-amino-2-mercaptoquinoline being in the form of a free compound or a salt of physiologically acceptable acids or bases.
2. The mercaptoquinoline according to claim 1 , wherein
R 7 denotes heterocyclyl, the heterocyclyl being bound via a carbon atom of the heterocyclyl.
3. The mercaptoquinoline according to claim 1 , wherein
R 1 , R 2 , R 3 and R 4 each independently of the others represents H; F; Cl; CN; OCF 3 ; SCF 3 ; CF 3 ; CH 3 or OCH 3 ; and
R 5 denotes H, F, Cl, OCF 3 , SCF 3 , C 1-6 -alkyl, O—C 1-6 -alkyl, or S—C 1-6 -alkyl.
4. The mercaptoquinoline according claim 1 , wherein
R 7 represents C 2-6 -alkyl or C 2-6 -heteroalkyl, saturated or unsaturated, branched or unbranched, unsubstituted; C 3-8 -cycloalkyl or heterocyclyl, saturated or unsaturated, unsubstituted; phenyl, furyl, thienyl or pyridyl, in each case unsubstituted or mono- or poly-substituted by one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, CN; CF 3 , OCF 3 , SCF 3 , CH 3 and OCH 3 .
5. The mercaptoquinoline according to claim 1 , wherein
n represents 1 and R 7 represents aryl or heteroaryl, in each case unsubstituted or mono- or poly-substituted.
6. The mercaptoquinoline according to claim 1 , selected from the group consisting of:
1 2-cyclohexyl-N-(2-(2-(phenylsulfonyl)ethylthio)quinolin-3-yl)acetamide;
2 N-(2-(2-(phenylsulfonyl)ethylthio)quinolin-3-yl)-2-(thiophen-2-yl)acetamide;
3 3-cyclohexyl-N-(2-(2-(phenylsulfonyl)-ethylthio)quinolin-3-yl)propanamide;
4 N-(2-(pentylthio)quinolin-3-yl)-2-(thiophen-2-yl)acetamide;
6 N-(2-(2-(phenylthio)ethylthio)quinolin-3-yl)-2-(thiophen-2-yl)acetamide;
7 N-(2-(ethylthio)quinolin-3-yl)-2-(thiophen-2-yl)acetamide;
9 N-(2-(ethylthio)quinolin-3-yl)-3,3-dimethylbutanamide;
10 N-[2-ethylsulfanyl-7-(trifluoromethyl)-quinolin-3-yl]-2-thiophen-2-yl-acetamide;
11 N[2-ethylsulfanyl-7-(trifluoromethyl)-quinolin-3-yl]-3,3-dimethyl-butyramide
12 3-cyclopentyl-N-[2-ethylsulfanyl-7-(trifluoromethyl)-quinolin-3-yl]propionamide
13 2-cyclohexyl-N-(2-ethylsulfanyl-quinolin-3-yl)-acetamide;
14 2-(5-bicyclo[2.2.1]heptanyl)-N-(2-ethylsulfanyl-quinolin-3-yl)-acetamide
15 3-cyclopentyl-N-(2-ethylsulfanyl-quinolin-3-yl)-propionamide
16 2-(5-bicyclo[2.2.1]heptanyl)-N-[2-ethylsulfanyl-7-(trifluoromethyl)-quinolin-3-yl]-acetamide
17 3-cyclopentyl-N-[2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinolin-3-yl]-propionamide
18 N-[2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinolin-3-yl]-2-thiophen-2-yl-acetamide,
and the physiologically acceptable salts thereof.
7. A pharmaceutical composition comprising at least one 3-amino-2-mercaptoquinoline according to claim 1 , in the form of an individual stereoisomer or a mixture thereof, in the form of a free compound and/or a physiologically acceptable salt thereof, and optionally one or more suitable additives and/or auxiliary substances and/or optionally further active ingredients.